2012Journal of Clinical Pulmonary MedicineRequires access

Clinical analysis of infection caused by Acinetobacter baumannii

Ting Wang

Open publisher page 0 citations

Abstract

Objective To learn the distribution of Acinetobacter baumannii bacteria in clinical and the drug resistance to common antibiotics.Methods A retrospective statistical analysis of 126 specimens of Acinetobacter baumannii,including specimen source,distribution departments of sample sections,antibiotic resistance,and general conditiong of the patients was made.Results The most common primary diseases of 95 patients infected by Acinetobacter baumannii were respiratory system diseases.Acinetobacter baumannii was mostly detected by sputum samples.The resistance of Acinetobacter baumannii was serious.Polymyxin B had the lowest resistance,amikacin and minocycline next to it.Imipenem,meropenem and Cefperazone Sulbactam had higher resistance.All patients had history of using antibiotics.Multi-drug resistant and Pan-drug resistant Acinetobacter baumannii were accounted for 96.03%.Conclusions The clinicians should use antibiotics reasonably,strengthen the monitoring of Acinetobacter baumannii resistance and reduce drug resistant strains.

About this research paper

What this paper is about

Objective To learn the distribution of Acinetobacter baumannii bacteria in clinical and the drug resistance to common antibiotics.Methods A retrospective statistical analysis of 126 specimens of Acinetobacter baumannii,including specimen source,distribution departments of sample sections,antibiotic resistance,and general conditiong of the patients was made.Results The most common primary diseases of 95 patients infected by Acinetobacter baumannii were respiratory system diseases.Acinetobacter baumannii was mostly detected by sputum samples.The resistance of Acinetobacter baumannii was serious.Polymyxin B had the lowest resistance,amikacin and minocycline next to it.Imipenem,meropenem and Cefperazone Sulbactam had higher resistance.All patients had history of using antibiotics.Multi-drug resistant and Pan-drug resistant Acinetobacter baumannii were accounted for 96.03%.Conclusions The clinicians should use antibiotics reasonably,strengthen the monitoring of Acinetobacter baumannii resistance and reduce drug resistant strains.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To learn the distribution of Acinetobacter baumannii bacteria in clinical and the drug resistance to common antibiotics.Methods A retrospective statistical analysis of 126 specimens of Acinetobacter baumannii,including specimen source,distribution departments of sample sections,antibiotic resistance,and general conditiong of the patients was made.Results The most common primary diseases of 95 patients infected by Acinetobacter baumannii were respiratory system diseases.Acinetobacter baumannii was mostly detected by sputum samples.The resistance of Acinetobacter baumannii was serious.Polymyxin B had the lowest resistance,amikacin and minocycline next to it.Imipenem,meropenem and Cefperazone Sulbactam had higher resistance.All patients had history of using antibiotics.Multi-drug resistant and Pan-drug resistant Acinetobacter baumannii were accounted for 96.03%.Conclusions The clinicians should use antibiotics reasonably,strengthen the monitoring of Acinetobacter baumannii resistance and reduce drug resistant strains.

Key concepts: Acinetobacter baumannii, Medicine, Amikacin, Sulbactam, Imipenem, Microbiology, Meropenem, Drug resistance

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical analysis of infection caused by Acinetobacter baumannii — Research Paper | ScholarLens